ACELYRIN

Read more
Shao-Lee Lin's photo - Co-Founder & CEO of ACELYRIN

Co-Founder & CEO

Shao-Lee Lin

CEO Approval Rating

90/100

Founded

2020

Status

PrivateIndependent Company

Social Links

Est. Annual Revenue
$2.1M
Agree?
Est. Employees
15
Agree?
Funding
$250M

ACELYRIN Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

ACELYRIN News

ACELYRIN Press Releases

ACELYRIN Headquarters

23371 Mulholland Dr. PMB 417

Woodland Hills, California91364

Driving Directions »

ACELYRIN Summary

ABOUT

Overview

ACELYRIN is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of inflammatory diseases. ACELYRIN was founded in 2020. ACELYRIN's headquarters is located in Woodland Hills, California, USA 91...

CEO

ACELYRIN's Co-Founder & CEO, Shao-Lee Lin, currently has an approval rating of 90%. ACELYRIN's primary competitors are Evommune, ValenzaBio & Xalud.

Acquisitions

There have been no acquisitions found related to ACELYRIN

Investments

Recent investment data cannot be found related to ACELYRIN

Frequently Asked Questions about ACELYRIN

  1. When was ACELYRIN founded?

    ACELYRIN was founded in 2020
  2. Who is ACELYRIN's CEO?

    ACELYRIN's CEO is Shao-Lee Lin
  3. How much revenue does ACELYRIN generate?

    ACELYRIN generates $2.1M in revenue
  4. How much funding does ACELYRIN have?

    ACELYRIN has historically raised $250M in funding
  1. Where is ACELYRIN's headquarters?

    ACELYRIN's headquarters is in Woodland Hills California, USA
  2. How many employees does ACELYRIN have?

    ACELYRIN has 15 employees
  3. What sector does ACELYRIN operate in?

    ACELYRIN is in Pharmaceuticals, Biotechnology
  4. Who are ACELYRIN's competitors?

    ACELYRIN's top competitors are Evommune, ValenzaBio, Xalud

Trending Companies